Le Lézard
Classified in: Health
Subject: PER

Cambia Health Solutions hires Oliver Kim as Director of Federal Policy


PORTLAND, Ore., Jan. 16, 2020 /PRNewswire/ -- Cambia Health Solutions is pleased to welcome Oliver Kim as Director of Federal Policy. Kim joins Cambia's Public Affairs and Policy team based in Washington, D.C. and will spearhead policy and regulatory initiatives aimed at helping improve health care for people and their families.

Oliver Kim, Director, Federal Policy, Cambia Health Solutions

Kim brings nearly two decades of experience in law and health policy as a former congressional advisor and health care advocate. He served in the U.S. Senate as a senior advisor to Senator Debbie Stabenow (D-MI) and later as deputy director for the Special Committee on Aging. Additionally, he served as legislative director for Planned Parenthood, providing guidance on implementing the Affordable Care Act

"In this complex and fluid policy environment, Oliver's extensive knowledge and experience brings additional depth and leadership to our policy team," said Jennifer Danielson, Senior Vice President, Public Affairs and Policy. "We are thrilled to have him further Cambia's mission to advance health care solutions that promote affordability, transparency and empower consumers."

Kim has a BA in English and history from Indiana University, a JD from the University of Minnesota, and an LLM from Georgetown University.

About Cambia Health Solutions
Cambia Health Solutions, headquartered in Portland, Oregon, is a total health solutions company dedicated to transforming health care. We are a family of more than 20 companies that work together to make the health care system more economically sustainable and efficient for people and their families. Our company reaches more than 70 million Americans nationwide, including more than 2.6 million people in the Pacific Northwest who are enrolled in our regional health plans, which have served the region for more than 100 years. To learn more about us, visit CambiaHealth.com or Twitter.com/cambia.

 

Cambia Health Solutions

SOURCE Cambia Health Solutions


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: